 Srikant Ramaswami |
Srikant (Sri) Ramaswami, executive VP/healthcare at rbb Communications, has joined Caris Life Sciences as VP-chief communications officer.
Prior to rbb, the 20-year pharma PR veteran worked at Merck, Pfizer and Johnson & Johnson.
At J&J, he spearheaded its pharmaceuticals effort in China and then served as VP/Asia-Pacific in the medical devices group.
Irving, TX-based CLS' molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps doctors/cancer patients make more precise and personalized treatment decisions.
CLS relies on The Ruth Group for media relations work.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
